News Conference News ACC 2019 Renal Denervation May Lower Treatment Burden, as Well as Blood Pressure: RADIANCE-HTN SOLO Michael O'Riordan April 01, 2019
News Conference News WCC 2018 Apps? Wearables? Probing Mobile Tech’s Potential to Boost Cardiac Rehab Todd Neale December 07, 2018
News Conference News WCC 2018 True Resistant Hypertension Is Prevalent Worldwide Todd Neale December 07, 2018
News Daily News FDA Charts Path for ‘Resurrection’ of Device-Based Antihypertensive Therapies Michael O'Riordan December 06, 2018
News Conference News TCT 2018 RADIOSOUND-HTN Suggests Ultrasound May Be Best for Renal Denervation Todd Neale September 26, 2018
Presentation TCT 2018 RADIOSOUND-HTN: A Three-Arm Randomized Trial of Different Renal Denervation Devices and Techniques in Patients With Resistant Hypertension Presenter: Felix Mahfoud, Patrick W. Serruys, Philipp Lurz September 25, 2018
News Conference News TCT 2018 Untreated Accessory Arteries Dampen Renal Denervation Response: RADIANCE-HTN SOLO Todd Neale September 21, 2018
News Conference News TCT 2018 TCT 2018: Mitral Interventions, Stent Wars, Practical Skills, and More Shelley Wood September 17, 2018
News Industry News ReCor Medical To Release of Clinical Trial Results 23 May at EuroPCR in Paris May 17, 2018
News Conference News CRT 2018 Radial Access PCI Reduces Risk of Mortality and Bleeding in VALIDATE-SWEDEHEART Michael O'Riordan March 06, 2018
News Conference News ESC 2017 Renal Denervation: Proof-of-Concept Study Gives Fresh Jolt to Fizzled Field Todd Neale August 28, 2017
News Daily News FDA Clearance of Modified Devices Relies Heavily on Weak Studies, Surrogate Endpoints Michael O'Riordan August 16, 2017
Presentation TCT 2016 Neuromodulation for the Treatment of Resistant Hypertension: First-In-Human Evaluation of an Implanted Median Nerve Stimulator Presenter: Emerson C. Perin, Mark W.I. Webster November 01, 2016
News Features Future of Renal Denervation May Hinge on a Handful of Small Studies Todd Neale February 14, 2016
News Daily News Renal Denervation Trials Have Largely Fallen Victim to Unintentional Bias Todd Neale January 19, 2016
News Industry News Vascular Dynamics’ MobiusHD™ System Receives CE Mark for the Treatment of Resistant Hypertension January 05, 2016
Presentation TCT 2015 TCT 90: Sustained Beneficial Effects of Multielectrode Renal Denervation on Cardiac Adaptations in Resistant Hypertension A 24-Month Follow-up Study Presenter: Michael A. Weber, Stephen G. Worthley, Konstantinos Tsioufis October 13, 2015
Presentation TCT 2015 TCT 89: Renal Sympathetic Denervation in Treatment-Resistant Essential Hypertension a Sham-Controlled, Double-blinded Randomized Trial (RESET trial) Presenter: Michael A. Weber, Stephen G. Worthley, Ole Mathiassen October 13, 2015
Presentation TCT 2015 TCT 87: Noninvasive Renal Denervation Study Using Externally Delivered Focused Ultrasound in Severe Resistant Hypertension One-Year Follow-up Results Presenter: Michael A. Weber, Stephen G. Worthley, Roland E Schmieder October 13, 2015
Presentation TCT 2015 TCT 86: Safety and Performance of the Next-Generation EnligHTN Renal Denervation System in Patients With Drug-Resistant Hypertension 24-Month Results From a First-in-Human Multicentre Study Presenter: Michael A. Weber, Stephen G. Worthley October 13, 2015